1. Home
  2. MYO vs LTRN Comparison

MYO vs LTRN Comparison

Compare MYO & LTRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Myomo Inc.

MYO

Myomo Inc.

N/A

Current Price

$0.69

Market Cap

36.9M

Sector

Health Care

ML Signal

N/A

Logo Lantern Pharma Inc.

LTRN

Lantern Pharma Inc.

N/A

Current Price

$2.52

Market Cap

31.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
MYO
LTRN
Founded
2004
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Specialties
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
36.9M
31.5M
IPO Year
2017
2020

Fundamental Metrics

Financial Performance
Metric
MYO
LTRN
Price
$0.69
$2.52
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
1
Target Price
$7.67
$25.00
AVG Volume (30 Days)
412.0K
44.0K
Earning Date
06-09-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,000,000,000.00
N/A
Revenue This Year
$15.92
N/A
Revenue Next Year
$21.49
N/A
P/E Ratio
N/A
N/A
Revenue Growth
40814.79
N/A
52 Week Low
$0.64
$2.45
52 Week High
$5.62
$5.74

Technical Indicators

Market Signals
Indicator
MYO
LTRN
Relative Strength Index (RSI) 39.44 36.80
Support Level $0.68 $2.49
Resistance Level $1.03 $3.65
Average True Range (ATR) 0.07 0.21
MACD -0.00 0.01
Stochastic Oscillator 25.21 10.94

Price Performance

Historical Comparison
MYO
LTRN

About MYO Myomo Inc.

Myomo Inc is a wearable medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. The MyoPro myoelectric upper limb orthosis product is registered with the Food and Drug Administration as a Class II medical device. The company provides the devices to patients and bills their insurance companies directly, sometimes utilizing the clinical services of orthotics and prosthetics providers for which a fee is paid. The company sells the product to orthotics and prosthetics providers around the world and the Veterans Health Administration (VA).

About LTRN Lantern Pharma Inc.

Lantern Pharma Inc is an AI company transforming the cost, pace, and timeline of oncology drug discovery and development. Its proprietary AI and machine learning (ML) platform, RADR, uses oncology-focused data points and advanced ML algorithms to solve billion-dollar, real-world problems in cancer drug development. The group's growing pipeline of precision therapies has been accelerated using AI and input from world-class scientific advisors and collaborators.

Share on Social Networks: